Will the thyroglobulin assay with lower functional sensitivity whilst the patients are on L-T4 treatment replace the TSH-stimulated thyroglobulin assay in the follow-up of patients with differentiated thyroid cancer?;O ensaio de tiroglobulina com melhor sensibilidade funcional enquanto os pacientes tomam L-T4 substituirá a tiroglobulina estimulada pelo TSH no seguimento dos pacientes com câncer diferenciado da tiróide?

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 51, Issue 5, 2007, Pages 862-866

  Maciel, Rui M B ^a,b  

^a Fleury   (Brazil)

^b Laboratório de Medicina Molecular   (Brazil)

Author keywords

Differentiated thyroid carcinoma; Functional sensitivity; Sensitivity; Stimulated thyroglobulin; Thyroglobulin

Indexed keywords

EID: 35348880922     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302007000500026     Document Type: Review

References (24)

1. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006;16:109-53.
2. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JWA, Wiersinga W; and the European Thyroid Cancer Task Force. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006;154:787-803.
3. Maia AL, Ward LS, Carvalho GA, Graf H, Maciel RMB, Rosário PW, et al. Nódulos de tiróide e câncer diferenciado de tiróide: consenso brasileiro. Arq Bras Endocrinol Metab 2007;51/5:-.
4. Durante C, Haddy N, Baudin E, Leboulleux S, Hartl D, Travagli JP, et al. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab 2006;91:2892-9.
5. Schlumberger M, Berg G, Cohen O, Duntas L, Jarnar F, Jarzab B, et al. Follow-up of low risk patients with differentiated thyroid carcinoma: an European perspective. Eur J Endocrinol 2004;150:105-12.
6. Mazzaferri EL, Robbins RJ, Braverman LE, Pacini F, Haugen BR, Wartofsky L, et al. Author's response: A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 2003;88:4508-9.
7. Duntas LH, Biondi B. Short-term hypothyroidism after L-T4 withdrawal in patients with differentiated thyroid cancer: clinical and quality of life consequences. Eur J Endocrinolol 2007;156:13-9.
8. Mazzaferri EL, Robbins RJ, Spencer CA, Braverman LE, Pacini F, Wartofsky L, et al. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 2003;88:1433-41.
9. Spencer CA, Bergoglio LM, Kazarozyan M, Fatemi S, LoPresti JS. Clinical impact of thyroglobulin (Tg) and Tg antibody method differences on the management of patients with differentiated thyroid carcinomas. J Clin Endocrinol Metab 2005;90:5556-75.
10. Wunderlich G, Zophel K, Crook L, Smith S, Smith BR, Franke WG. A high-sensitivity enzyme-linked immunosorbent assay for serum thyroglobulin. Thyroid 2001;11:819-24.
11. Mongenthaler NG, Froelich J, Rendl J, Willnich M, Alonso C, Bergmann A, et al. Technical evaluation of a new immunoradiometric and an immunoluminometric assay for thyroglobulin. Clin Chem 2002;48:1077-83.
12. Zophel K, Wunderlich G, Smith BR. Serum thyroglobulin measurements with a high-sensitivity assay enzyme-linked immunosorbent assay: is there a clinical benefit in patients with differentiated thyroid carcinoma? Thyroid 2003;13:861-5.
13. Zophel K, Wunderlich G, Franke WG. Initial experiences with a highly sensitive enzyme-linked-immuno-sorbent assay (ELISA) for measurement of thyroglobulin in patients with differentiated thyroid carcinoma. J Lab Med 2002;26:425-33.
14. Zophel K, Wunderlich G, Kotzerke J. A highly sensitive thyroglobulin assay has superior diagnostic sensitivity for recurrence of differentiated thyroid cancer in patients undergoing TSH suppression. J Nucl Med 2006;47:552-3.
15. Giovanella L, Ceriani L, Ghelfo A, Keller F, Sacchi A, Maffioli M, et al. Thyroglobulin assay during thyroxine treatment in low-risk differentiated thyroid cancer management: comparison with recombinant assay and imaging procedures. Clin Chem Lab Med 2006;44:648-52.
16. Smallridge RC, Meek SE, Morgan MA, Gates GS, Fox TP, Grebe S, et al. Monitoring thyroglobulin in a sensitive immunoassay has comparable sensitivity to recombinant human TSH-stimulated thyroglobulin in follow-up of thyroid cancer patients. J Clin Endocrinol Metab 2007;92:82-7.
17. Schlumberger M, Hitzel A, Toubert ME, Corone C, Troalen F, Schlageter MH, et al. Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients. J Clin Endocrinol Metab 2007;92:[Epub ahead of print].
18. Biscolla RP, Ikejiri ES, Mamone MC, Nakabashi CC, Andrade VP, Kasamatsu TS, et al. Diagnóstico de metástases de carcinoma papilífero de tiróide através da dosagem de tiroglobulina no líquido obtido da lavagem da agulha utilizada na punção aspirativa. Arq Bras Endocrinol Metab 2007;51/3:419-25.
19. Kobayashi T, Goto R, Ito K, Mitsumori K. Prostate cancer screening strategies with re-screening interval determined by individual baseline prostate-specific antigen values are cost-effective. Eur J Surg Oncol 2007;[Epub ahead of print].
20. Ankerst DP, Thompson IM. Sensitivity and specificity of prostate-specific antigen for prostate cancer detection with high rates of biopsy verification. Arch Ital Urol Androl 2006;78:125-9.
21. Rosário P, Borges M, Reis J, Alves MF. Effect of suppressive therapy with levothyroxine on the reduction of serum thyroglobulin after total thyroidectomy. Thyroid 2006;16:199-200.
22. Rosário PW, Borges MA, Fagundes TA, Franco AC, Purisch S. Is stimulation of thyroglobulin useful in low-risk patients with thyroid carcinoma and undetectable Tg on thyroxine and negative neck ultrasound? Clin Endocrinol 2005;62:121-5.
23. 131I scanning useful after total thyroid ablation for differentiated thyroid cancer? J Clin Endocrinol Metab 2000;85:175-8.
24. Torlontano M, Attard M, Croceti U, Tumino S, Bruno R, Costante G, et al. Follow-up of low risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases. J Clin Endocrinol Metab 2004;89:3402-7.